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Patients Undergoing Percutaneous Coronary
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MaBACKGROUND Rates of referral to cardiac rehabilitation after percutaneous coronary intervention (PCI) have been
historically low despite the evidence that rehabilitation is associated with lower mortality in PCI patients.
OBJECTIVES This study sought to determine the prevalence of and factors associated with referral to cardiac reha-
bilitation in a national PCI cohort, and to assess the association between insurance status and referral patterns.
METHODS Consecutive patients who underwent PCI and survived to hospital discharge in the National Cardiovascular
Data Registry between July 1, 2009 and March 31, 2012 were analyzed. Cardiac rehabilitation referral rates, and patient
and institutional factors associated with referral were evaluated for the total study population and for a subset of
Medicare patients presenting with acute myocardial infarction.
RESULTS PatientswhounderwentPCI (n¼ 1,432,399) at 1,310participatinghospitalswere assessed. Cardiac rehabilitation
referral rates were 59.2% and 66.0% for the overall population and the AMI/Medicare subgroup, respectively. In multi-
variable analyses, presentation with ST-segment elevation myocardial infarction (odds ratio 2.99; 95% conﬁdence interval:
2.92 to 3.06) and non–ST-segment elevationmyocardial infarction (odds ratio: 1.99; 95% conﬁdence interval: 1.94 to 2.03)
were associated with increased odds of referral to cardiac rehabilitation. Models adjusted for insurance status showed
signiﬁcant site-speciﬁc variability in referral rates, with more than one-quarter of all hospitals referring <20% of patients.
CONCLUSIONS Approximately 60% of patients undergoing PCI in the United States are referred for cardiac rehabili-
tation. Site-speciﬁc variation in referral rates is signiﬁcant and is unexplained by insurance coverage. These ﬁndings
highlight the potential need for hospital-level interventions to improve cardiac rehabilitation referral rates after
PCI. (J Am Coll Cardiol 2015;65:2079–88) © 2015 by the American College of Cardiology Foundation.P articipation in cardiac rehabilitation aftermyocardial infarction and/ormyocardial revas-cularization is associated with better cli-
nical outcomes, including lower all-cause mortality,
cardiac-speciﬁcmortality, re-hospitalization, revascu-
larization, and cardiovascular disease–related func-
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reported performance measure instituted by the Cen-
ters for Medicare and Medicaid Services (CMS) in
2014 (14).
Lack of referral to cardiac rehabilitation is
an important impediment to participation in reha-
bilitation programs (15,16). Although previous
regional analyses demonstrated low rates of referral
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AB BR EV I A T I O N S
AND ACRONYM S
ACE = angiotensin-converting
enzyme
AMI = acute myocardial
infarction
ARB = angiotensin-receptor
blocker
CABG = coronary artery
bypass graft
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2081cardiac rehabilitation remains deﬁcient in contem-
porary interventional practice across the United
States (17). We used the National Cardiovascular
Data Registry (NCDR) to assess cardiac rehabilitation
referral rates and both patient- and hospital-level
factors associated with referral in patients who
underwent PCI in the United States. In addition, we
evaluated insurance coverage, which is a frequently
cited barrier to cardiac rehabilitation referral, in
relation to national referral patterns.FIGURE 1 Temporal Trends in Cardiac Rehabilitation Referral Rates
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CAD = coronary artery disease
CI = conﬁdence interval
CMS = Centers for Medicare
and Medicaid Services
EF = ejection fraction
NCDR = National
Cardiovascular Data Registry
NSTEMI = non–ST-segment
elevation myocardial infarction
OR = odds ratio
PCI = percutaneous coronary
interventionMETHODS
DATA SOURCE. Data were analyzed from the NCDR’s
CathPCI registry program. The program is jointly
sponsored by the American College of Cardiology
and the Society for Cardiovascular Angiography and
Interventions, and has been described previously
(18,19). Data on consecutive patients who underwent
PCI, as collected from cardiac catheterization labora-
tories across the United States, include baseline
demographic and clinical characteristics, such as
admission symptoms and risk factors, as well as de-
tailed procedural and angiographic information.
Discharge medications and in-patient referral to car-
diac rehabilitation are recorded for all patients who
are discharged. Data collected using CathPCI registry
version 4 were used for this analysis (20).
Waiver of written informed consent and authori-
zation for this study was granted by Chesapeake
Research Review Incorporated.
STUDY POPULATION. The study population was
composed of all consecutive patients who underwent
PCI at the participating hospitals between July 1, 2009
and March 31, 2012. Patients were excluded if they
died in-hospital, or were discharged to nursing home
facilities, acute care hospitals, hospice, or who left
against medical advice.
STATISTICAL ANALYSIS. The primary outcome was
referral to cardiac rehabilitation. Overall rates of
referral to cardiac rehabilitation were determined for
the total study period, and temporal trends were
assessed quarterly.
Baseline characteristics were compared for pa-
tients who were referred and not referred to car-
diac rehabilitation using Pearson’s chi-square tests
for categorical variables and Wilcoxon rank sum tests
for continuous and ordinal variables. We also
assessed other quality measures at hospital dis-
charge, including discharge on aspirin, beta-blockers,
angiotensin-converting enzyme (ACE) inhibitors/
angiotensin-receptor blockers (ARBs) if the ejectionfraction (EF) was <40%, statins, and any
P2Y12 antagonist. McNemar’s test for paired
proportions was used to compare rates of
referral to cardiac rehabilitation with rates of
the previously mentioned quality-of-care
measures.
Multivariable logistic regression was used
to estimate the effect of each statistically sig-
niﬁcant univariate predictor on the primary
outcome of referral to cardiac rehabilitation.
A random effects model was ﬁt to assess the
association between patient- and hospital-
level covariates and rehabilitation referral
rates by deconstructing each covariate into its
within- and across-center components.
To assess for interhospital variation in
cardiac rehabilitation referral rates, a logistic
regression model was ﬁt with a random effect
on the hospital, and the variance component
of the model was assessed. A variance signif-
icantly different from zero denoted statisti-
cally signiﬁcant variation in referral rates
between sites. To evaluate the association between
insurance status and observed interhospital variation
in referral rates, the model was adjusted for insurance
type, and the variance was reassessed. A 95% boot-
strap conﬁdence interval (CI) was constructed for the
relative change in variance between the adjusted and
TABLE 1 Baseline Characteristics of Patients Referred and Not Referred to
Cardiac Rehabilitation After PCI Within the Overall Population
Overall
(N ¼ 1,432,399)
Patients
With Cardiac
Rehab Referral
(n ¼ 848,285)
Patients
Without Cardiac
Rehab Referral
(n ¼ 584,114) p Value
Demographics
Age, yrs 65 (56,73) 64 (56,73) 65 (56,74) <0.001
Female 461,560 (32.2) 270,148 (31.8) 191,412 (32.8) <0.001
Race/ethnicity <0.001
Caucasian 1,265,246 (88.3) 763,094 (90.0) 502,152 (86.0)
African American 115,389 (8.1) 60,024 (7.1) 55,365 (9.5)
Hispanic 70,019 (4.9) 31,242 (3.7) 38,777 (6.6)
Other 44,534 (3.1) 22,079 (2.6) 22,455 (3.8)
BMI, kg/m2 29.1 (25.8,33.3) 29.2 (25.8,33.4) 29.0 (25.7,33.2) <0.001
Insurance status
Private 917,185 (64.0) 554,999 (65.4) 362,186 (62.0) <0.001
Medicare 721,824 (50.4) 421,940 (49.7) 299,884 (51.3) <0.001
Medicaid 128,298 (9.0) 69,157 (8.2) 59,141 (10.1) <0.001
Other 61,363 (4.3) 35,304 (4.2) 26,059 (4.5) <0.001
None 146,665 (10.2) 88,369 (10.4) 58,296 (10.0) <0.001
Medical history
Current/recent smoker 395,467 (27.6) 243,025 (28.7) 152,442 (26.1) <0.001
Hypertension 1,171,261 (81.8) 684,691 (80.7) 486,570 (83.3) <0.001
Dyslipidemia 1,148,137 (80.2) 678,550 (80.1) 469,587 (80.5) <0.001
Previous MI 424,883 (29.7) 249,717 (29.4) 175,166 (30.0) <0.001
Previous CHF 159,012 (11.1) 89,927 (10.6) 69,085 (11.8) <0.001
Previous valve surgery 20,418 (1.4) 11,394 (1.3) 9,024 (1.5) <0.001
Previous PCI 584,233 (40.8) 335,613 (39.6) 248,620 (42.6) <0.001
Previous CABG 268,148 (18.7) 153,638 (18.1) 114,510 (19.6) <0.001
Cerebrovascular disease 168,933 (11.8) 98,040 (11.6) 70,893 (12.1) <0.001
Peripheral artery disease 173,451 (12.1) 99,036 (11.7) 74,415 (12.7) <0.001
Chronic lung disease 210,238 (14.7) 123,744 (14.6) 86,494 (14.8) <0.001
Diabetes mellitus 513,888 (35.9) 295,136 (34.8) 218,752 (37.5) <0.001
Presenting condition
CAD <0.001
No angina 126,423 (8.8) 68,385 (8.1) 58,038 (9.9)
Atypical chest pain 41,694 (2.9) 22,865 (2.7) 18,829 (3.2)
Stable angina 258,264 (18.0) 138,684 (16.4) 119,580 (20.5)
Unstable angina 539,378 (37.7) 306,857 (36.2) 232,521 (39.8)
NSTEMI 253,626 (17.7) 163,721 (19.3) 89,905 (15.4)
STEMI 212,644 (14.8) 147,527 (17.4) 65,117 (11.2)
HF/NYHA functional
class within 2 weeks
<0.001
No HF 1,307,718 (91.3) 774,840 (91.4) 532,878 (91.3)
I 14,963 (1.0) 9,454 (1.1) 5,509 (0.9)
II 38,467 (2.7) 22,127 (2.6) 16,340 (2.8)
III 44,115 (3.1) 25,311 (3.0) 18,804 (3.2)
IV 26,603 (1.9) 16,250 (1.9) 10,353 (1.8)
Cardiogenic shock within 24 h 16,033 (1.1) 10,686 (1.3) 5,347 (0.9) <0.001
Cardiac arrest within 24 h 18,857 (1.3) 12,771 (1.5) 6,086 (1.0) <0.001
Cardiomyopathy/LV systolic
dysfunction
135,267 (9.4) 79,751 (9.4) 55,516 (9.5) 0.038
Continued on the next page
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2082unadjusted models to determine the statistical sig-
niﬁcance of any noted difference. The model was
further adjusted for available hospital-level char-
acteristics (number of beds, PCI volume, urban or
rural location, teaching or nonteaching status, andgeographic region) with bootstrap analysis to assess
for differences in variance.
Analyses were performed using SAS version 9.2
(SAS Institute, Cary, North Carolina).
ACUTEMYOCARDIAL INFARCTION/MEDICARE SUBGROUP
ANALYSIS. To further evaluate the relationship be-
tween insurance status and cardiac rehabilitation
referral rates, an analysis was performed that evalu-
ated the trends and predictors of referral to cardiac
rehabilitation among PCI patients with Medicare and
who presented with AMI as a representative subset of
patients with deﬁnitive insurance coverage for car-
diac rehabilitation. Univariate and multivariate ana-
lyses, as outlined previously, were repeated for this
subset of the study population.
RESULTS
RATES OF REFERRAL TO CARDIAC REHABILITATION
AND OTHER ACUTE MYOCARDIAL INFARCTION
QUALITY-OF-CARE MEASURES. The sample study
population consisted of 1,432,399 patients who un-
derwent PCI between July 1, 2009 and March 31, 2012
at 1,310 hospitals across the United States. The over-
all cardiac rehabilitation referral rate for all patients
during the 2-year study period was 59.2%. There was
minimal change in referral rates over the study
period, with quarterly rates ranging from 57.9% to
61.2% (Figure 1). In contrast, rates were signiﬁcantly
higher for other AMI quality-of-care indexes,
including discharge on aspirin (97.5%), statins
(89.8%), beta-blockers (84.8%), ACE inhibitors/ARBs
if EF was <40% (79.6%), and P2Y12 antagonists
(97.0%) (all p < 0.001) (Figure 2).
UNIVARIATE AND MULTIVARIATE PREDICTORS OF
REFERRAL. Baseline characteristics of PCI patients
who were and were not referred to cardiac rehabili-
tation are presented in Table 1. There were several
statistically signiﬁcant, but clinically small differ-
ences between the 2 groups. Patients referred to
cardiac rehabilitation were generally younger, men,
white, had private insurance carriers, were current or
recent smokers, and had higher body mass index
values. Referred patients were less likely to have
various medical co-morbidities, including hyper-
tension, dyslipidemia, cerebrovascular disease, pe-
ripheral artery disease, chronic lung disease, and
diabetes mellitus. A history of MI, congestive heart
failure, previous PCI, previous coronary artery by-
pass graft (CABG), and previous valve surgery were
all slightly less prevalent among patients referred
to rehabilitation programs. Notably, a higher pro-
portion of referred patients presented with AMI
TABLE 1 Continued
Overall
(N ¼ 1,432,399)
Patients
With Cardiac
Rehab Referral
(n ¼ 848,285)
Patients
Without Cardiac
Rehab Referral
(n ¼ 584,114) p Value
Intra- and
post-procedure events*
MI 28,651 (2.0) 16,740 (2.0) 11,911 (2.0) 0.006
Cardiogenic shock 8,072 (0.6) 5,249 (0.6) 2,823 (0.5) <0.001
HF 10,276 (0.7) 6,892 (0.8) 3,384 (0.6) <0.001
CVA/stroke 1,890 (0.1) 1,178 (0.1) 712 (0.1) 0.006
Tamponade 820 (0.1) 480 (0.1) 340 (0.1) 0.689
New requirement for dialysis 1,731 (0.1) 985 (0.1) 746 (0.1) 0.050
Other vascular complication 5,586 (0.4) 3,388 (0.4) 2,198 (0.4) 0.030
Bleeding within 72 h 21,400 (1.5) 13,101 (1.5) 8,299 (1.4) <0.001
Hospital characteristics
Number of beds 405 (274,564) 412 (286,573) 394 (260,550) <0.001
Location <0.001
Rural 164,727 (11.5) 104,871 (12.4) 59,856 (10.2)
Suburban 436,328 (30.5) 263,104 (31.0) 173,224 (29.7)
Urban 831,278 (58.0) 480,309 (56.6) 350,969 (60.1)
Teaching 715,383 (49.9) 427,424 (50.4) 287,959 (49.3) <0.001
Private/community hospitals 1,252,011 (87.4) 755,804 (89.1) 496,207 (85.0) <0.001
Region
West 218,298 (15.2) 107,091 (12.6) 111,207 (19.0) < 0.001
Northeast 213,095 (14.9) 108,300 (12.8) 104,795 (17.9) <0.001
Midwest 406,663 (28.4) 307,305 (36.2) 99,358 (17.0) <0.001
South 594,277 (41.5) 325,534 (38.4) 268,743 (46.0) <0.001
Annual PCI volume 714 (437,1150) 741 (448,1182) 692 (418,1122) <0.001
Values are median (interquartile range) or n (%). *Excluding deaths same day as procedure.
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; CVA ¼ cere-
brovascular accident; CHF ¼ congestive heart failure; HF ¼ heart failure; IQR ¼ inter-quartile range; MI ¼
myocardial infarction; NSTEMI ¼ non–ST-segment elevation MI; NYHA ¼ New York Heart Association; PCI ¼
percutaneous coronary intervention; STEMI ¼ ST-segment elevation MI.
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2083(non–ST-segment elevation myocardial infarction
[NSTEMI] or STEMI) or experienced cardiogenic shock
or cardiac arrest within 24 h of the PCI procedure.
Among hospital-level characteristics, patients re-
ferred to cardiac rehabilitation were more likely to
be from hospitals with more beds and that performed
a greater volume of PCIs (Table 1).
Factors independently associated with referral
to cardiac rehabilitation in the ﬁnal multivariate
model are displayed in Table 2. Among patient-level
covariates, presentation with STEMI (odds ratio
[OR]: 2.99; 95% CI: 2.92 to 3.06) and NSTEMI (OR:
1.99; 95% CI: 1.94 to 2.03) conferred the highest
likelihood of referral to cardiac rehabilitation, fol-
lowed by presentation with unstable angina (OR: 1.12;
95% CI: 1.10 to 1.14) and peri-procedural MI (OR: 1.42;
95% CI: 1.37 to 1.47). Older age and several medical
co-morbidities, including diabetes mellitus, periph-
eral artery disease, previous congestive heart failure,
and chronic lung disease, as well as a history of PCI,
CABG, or valve surgery were all associated with a
decreased likelihood of referral to cardiac rehabilita-
tion, although the absolute effects of these associa-
tions were small (Table 2).
Among institutional characteristics, a greater vol-
ume of PCIs, larger hospital size (denoted by num-
ber of hospital beds), private/community hospital
designation, and particular geographic locations were
associated with increased referral to cardiac rehabil-
itation. Notably, certain hospital-level covariates
(i.e., Midwest region [OR: 7.36; 95% CI: 5.08 to 10.67]
and private/community hospital [OR: 2.33; 95% CI:
1.34 to 4.05]) demonstrated robust effect sizes
compared with most patient-level factors.
SUBGROUP ANALYSIS: MEDICARE PATIENTS PRESENTING
WITH AMI. An analysis was performed, restricted to
patients who presented with AMI and who had Medi-
care coverage (n ¼ 196,214). The 2-year referral rate for
this subset of patients was 66.0%, with stable quar-
terly rates over the study period ranging from 64.4% to
67.4% (Figure 1). Rates of other AMI quality-of-care
determinants were the same or higher in the AMI/
Medicare subset compared with the overall
population.
The predictors of referral in this population were
broadly similar to those in the overall cohort and are
listed in Online Tables 1 and 2.
INTERHOSPITAL VARIATION IN CARDIAC REHABILITATION
REFERRAL RATES. Two logistic regression models
with a random effect on the hospital (one unadjusted
and the other adjusted for insurance type) were
constructed to assess interhospital variation in car-
diac rehabilitation referral rates. For each model, thevariance was signiﬁcantly different from zero
(p < 0.0001), which suggested signiﬁcant variation in
hospital-level referral rates whether or not insurance
type was considered. In an analysis of 400 bootstrap
samples, the ratio of variance components between
the adjusted and unadjusted models was 1.002 (95%
CI: 1.001 to 1.003), which denoted an increased vari-
ation in hospital-level referral rates after adjustment
for insurance type, and indicated insurance type as a
confounder for hospital-speciﬁc effects on referral
rates. However, the negligible increase in variation
(0.2% on average) suggested that insurance type did
not heavily inﬂuence the variation in cardiac reha-
bilitation referral rates observed across hospitals.
Figure 3 demonstrates the comparable distributions of
referral rates across hospital sites before and after
adjustment for insurance type, with the majority
of hospital sites displaying referral rates >80%
or <20% in each scenario. Site-speciﬁc variability in
referral rates persisted even after further adjustment
for hospital-level characteristics, with more than
one-quarter of all hospitals demonstrating referral
TABLE 2 Multivariate Predictors of Referral to Cardiac Rehabilitation After PCI in the
Overall Population
Effect OR 95% CI Chi Square p Value
Admission symptoms
(vs. no sx/no angina)
Stable angina 1.028 1.008–1.049 18,625.59 <0.001
ACS: unstable angina 1.121 1.100–1.142
ACS: NSTEMI 1.985 1.944–2.026
Atypical chest pain 1.005 0.973–1.039
ACS: STEMI 2.987 2.921–3.056
Intra/post-procedure MI 1.420 1.369–1.472 355.63 <0.001
Previous PCI 0.904 0.894–0.914 299.49 <0.001
Hospital region (vs. South)
Northeast 1.097 0.674–1.787 136.61 <0.001
Midwest 7.363 5.083–10.667
West 1.121 0.742–1.693
Dyslipidemia 1.059 1.045–1.073 69.20 <0.001
Age (per 5 yr) 0.988 0.985–0.991 68.50 <0.001
Peripheral artery disease 0.944 0.929–0.959 52.30 <0.001
Insurance private 1.058 1.041–1.074 50.76 <0.001
HF/NYHA functional class within
2 weeks (vs. no HF within 2 weeks)
III 1.067 1.035–1.100 46.36 <0.001
I 1.056 1.002–1.112
IV 1.096 1.055–1.139
II 1.063 1.030–1.098
Previous CABG 0.955 0.942–0.968 44.91 <0.001
Diabetes 0.964 0.953–0.974 44.10 <0.001
BMI per 5-U (when<30 kg/m2) 1.029 1.020–1.039 37.14 <0.001
Intra-/post-procedure new
requirement for dialysis
0.732 0.636–0.844 18.55 <0.001
Previous CHF 0.962 0.945–0.979 18.16 <0.001
Insurance none 0.956 0.935–0.978 14.97 <0.001
Previous valve surgery 0.929 0.891–0.969 12.00 <0.001
Chronic lung disease 0.977 0.963–0.991 10.04 0.002
Private/community hospital 2.335 1.345–4.054 9.07 0.003
Race (vs. white)
Hispanic 1.026 0.958–1.097 8.68 0.034
Other 0.959 0.930–0.989
African American 1.006 0.987–1.026
Intra-/post-procedure HF 1.081 1.014–1.151 5.78 0.016
Annual PCI volume (per 100) 1.050 1.009–1.093 5.63 0.018
Cardiac arrest within 24 h 1.055 1.006–1.106 4.89 0.027
Hospital beds (per 100) 1.109 1.010–1.219 4.67 0.031
Insurance Medicaid 0.979 0.960–0.998 4.53 0.033
Cerebrovascular disease 0.984 0.969–1.000 4.07 0.044
Previous MI 1.011 0.999–1.024 3.10 0.079
Hospital location (vs. urban)
Rural 1.378 0.888–2.138 2.44 0.296
Suburban 1.003 0.709–1.420
Current/recent smoker 1.010 0.997–1.022 2.24 0.134
Continued on the next page
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2084rates of <20%. The ratio of variance between the
unadjusted model and the model adjusted for both
insurance status and hospital characteristics was
0.994 (95% CI: 0.980 to 1.003), which suggested that
hospital characteristics assessed in our study were
not signiﬁcantly associated with the observed vari-
ability in referral rates.DISCUSSION
Our analyses demonstrated low cardiac rehabilita-
tion referral rates in the United States between
2009 and 2012, with minimal improvement over the
deﬁned 2-year study period and signiﬁcant vari-
ability across hospital sites. Under-referral was
widespread across patient types and not predicated
on patient risk, as most comorbidities demonstrated
only a weak association with referral rates. Similarly,
insurance coverage for cardiac rehabilitation had a
minimal effect on overall referral rates and inter-
hospital variability in referral patterns. Despite the
general notion that lack of insurance coverage is a
major barrier to rehabilitation referral, our data
suggest that other, unidentiﬁed factors are the pri-
mary determinants of decreased referral.
The beneﬁts of comprehensive cardiac rehabilita-
tion programs in CAD patients have been well noted,
including associated reductions in morbidity and
mortality, and improvements in functional status and
quality of life; these are presumed to be a result of
exercise training, psychological counseling, and a
consistent emphasis on preventive strategies (e.g.,
medication compliance and cardiovascular risk factor
modiﬁcation) (21–26). A number of studies have
demonstrated better outcomes in clinical trial and
sicker registry populations (2–5). Furthermore, in
a recent study of 2,395 PCI patients, participation
in cardiac rehabilitation was associated with a
45% to 47% reduction in 5-year all-cause mortality
(p < 0.001), which further supports the beneﬁts of
cardiac rehabilitation for post-procedural care (27).
Despite the considerable evidence regarding the
beneﬁts of cardiac rehabilitation for secondary pre-
vention in CAD, previous studies have demonstrated
low rates of participation in rehabilitation programs
in the United States (28,29). An analysis of 267,427
elderly Medicare beneﬁciaries reported that only
13.9% of patients with AMI and 31.0% of those who
had undergone CABG surgery participated in cardiac
rehabilitation after their index hospitalizations (30).
An assessment of potential barriers to participation
in cardiac rehabilitation in post-AMI patients cited
inpatient referral to cardiac rehabilitation as one of
the strongest predictors of program enrollment (OR:
6.14; 95% CI: 2.12 to 17.74) (31). A combined analysis
of 10 observational studies with a total of 30,000 CAD
patients highlighted insurance coverage, history of
previous MI, being English speaking, and admission
to a hospital with existing cardiac rehabilitation pro-
grams as the four primary determinants of referral
to cardiac rehabilitation (32). A regional analysis of
post-PCI referral patterns in Michigan displayed a
TABLE 2 Continued
Effect OR 95% CI Chi Square p Value
Cardiomyopathy or LV systolic dysfunction 1.013 0.994–1.031 1.74 0.187
Cardiogenic shock within 24 h 1.033 0.981–1.088 1.51 0.220
Intra-/post-procedure cardiogenic shock 1.043 0.972–1.120 1.35 0.245
Teaching hospital 0.827 0.579–1.181 1.09 0.296
Hypertension 0.993 0.980–1.007 0.89 0.345
Insurance other 0.988 0.962–1.014 0.82 0.365
Intra-/post-procedure bleeding within 72 h 1.015 0.973–1.058 0.45 0.502
BMI per 5-U (when $30 kg/m2) 1.002 0.996–1.008 0.33 0.563
Female 0.998 0.987–1.009 0.15 0.699
Intra/post-procedure CVA/stroke 0.974 0.852–1.114 0.15 0.701
Insurance Medicare 1.003 0.988–1.018 0.12 0.726
Intra-/post-procedure tamponade 1.032 0.842–1.265 0.09 0.763
Intra-/post-procedure other
vascular complication
1.005 0.928–1.089 0.01 0.905
ACS ¼ acute coronary syndrome(s); CI ¼ conﬁdence interval; LV ¼ left ventricular; OR ¼ odds ratio;
sx ¼ symptoms; other abbreviations as Table 1.
FIGURE 2 Cardiac Rehabilitation Referral and Other AMI Quality of Care Measures
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2085decreased likelihood of referral for most comorbid-
ities, and increased odds of referral among men,
younger patients, patients self-identiﬁed as white,
and patients with more severe or acute presentations,
including STEMI (17).
Our contemporary analysis of PCI patients across
the United States extends these previous studies in
several ways. Compared with previous analyses, we
observed that older patients, women, those with the
most comorbidities, and those with previous MI or
revascularizationwere less likely tobe referred to cardiac
rehabilitation, despite data that suggest that these pop-
ulations might beneﬁt most from rehabilitation pro-
grams (28,33,34). However, in our large national sample,
the effect sizes of these negative predictors were small,
which suggested minimal overall inﬂuence of patient
factors on rates of referral to cardiac rehabilitation.
Conversely, hospital-level characteristics in our
analysis demonstrated robust associations with
referral patterns. In particular, Midwest location and
private/community hospital designation were associ-
ated with marked increases in referral to cardiac
rehabilitation. However, a limited number of hospital
characteristics were available for inclusion in our
analysis. Therefore, it is likely that the aforementioned
hospital-level predictors of referral were confounders
for other, unmeasured institutional characteristics
such as the presence of automated discharge sets,
which have been associated with increased cardiac
rehabilitation referral rates in previous studies;
unfortunately, these data were unavailable for the
present analysis (35,36).
Lack of insurance coverage has been reported as a
negative predictor of referral to cardiac rehabilitation
and has been cited as a major reason for continued
low referral rates (37). In our analysis, insurance
coverage for rehabilitation programs had a negligible
effect on referral patterns. Despite a slight increase in
overall referral rates among Medicare patients who
presented with AMI, predictors of referral were rela-
tively unchanged. Notably, concurrent Medicaid sta-
tus conferred a decreased likelihood of referral,
whereas concurrent private insurance was associated
with increased referral. These data suggested that
insurance coverage for cardiac rehabilitation had, at
best, a modest effect on referral rates, but that type of
insurance might be a slightly stronger predictor of
referral patterns. However, insurance type might also
be a proxy for socioeconomic status, but these data
were unavailable for this study. Referral patterns
might be affected by unmeasured confounders such
as low income, which was previously reported as a
negative predictor of participation in rehabilitation
programs(30).Ourobservation thatnon-white racewas
FIGURE 3 Interhospital Variation in Cardiac Rehabilitation Referral Rates
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2086associated with decreased referral might also be con-
founded by the unavailable data on income and socio-
economic status. However, although participation in
cardiac rehabilitation might be affected by income-
related factors such as time away from work and
distance of rehabilitation center from home, theoreti-
cally, referral should not be affected in the setting of
available insurance coverage. It is possible that phy-
sicians preferentially refer those patients presumed
likely to participate in and beneﬁt from rehabilitation
programs, instead of referring all PCI patients to car-
diac rehabilitation and encouraging it as an integral
component of post-procedural, post-MI care (38,39).
The development and implementation of perfor-
mance measures to improve health care account-
ability has increased dramatically in the past decade,
particularly in the management of AMI, as greater
compliance with established care processes has
been associated with enhanced clinical outcomes
(40,41). Our study corroborated previous work
that demonstrated that rates of more established,
publicly reported AMI quality-of-care measures werec Rehabilitation
I volume;
al location;
farction (MI)
iabetes mellitus; 
art failure; 
onary intervention; 
rior valve surgery)
Magnitude of 
increased likelihood
 rehabilitation 
vention (PCI) 
(Greatest
influencing factor)
rehabilitation referral.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Presentation
with AMI and certain institutional variables are more strongly
associated with referral of patients for cardiac rehabilitation after
PCI than speciﬁc patient characteristics or insurance status, but
across the United States, rates of referral are relatively low
(approximately 60%).
TRANSLATIONAL OUTLOOK: Further investigations are
required to identify additional hospital-level factors associated
with referral for cardiac rehabilitation of patients undergoing PCI.
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2087signiﬁcantly higher than rates of referral to cardiac
rehabilitation. This suggested that deﬁciencies in
cardiac rehabilitation referral rates did not reﬂect a
broader lack of quality care for AMI patients (15,17).
The incorporation of referral to cardiac rehabilita-
tion as a new, publicly reported CMS performance
measure in 2014 may provide the impetus to improve
rates of referral across the country. As with other
performance measures of accountability, the prospect
of incentives for improved performance and penalties
for poor compliance will likely motivate prompt
identiﬁcation of sites with deﬁcient referral rates, and
concerted efforts (e.g., incorporation of automated
discharge checklists) to improve referral rates at
underperforming hospitals (35,42).
STUDY LIMITATIONS. First, the CathPCI Registry
contained only in-hospital data, such as referral to
cardiac rehabilitation before discharge; no follow-up
data were available to assess participation in rehabili-
tation programs or subsequent outcomes. Second, lack
of socioeconomic data might confound the noted as-
sociations between referral to cardiac rehabilitation
and insurance status or race. Third, as outlined previ-
ously, the limited availability of institutional charac-
teristics precluded a more detailed assessment of
hospital-level predictors of referral. Fourth, geo-
graphic proximity to cardiac rehabilitation sites was
associated with increased referral patterns; unfortu-
nately, such data were unavailable for geospatial an-
alyses (43). Finally, the study cohort was derived from
hospitals that participated in a quality improvement
initiative andweremore likely to implement evidence-
based measures. Accordingly, cardiac rehabilitation
referral rates reported in this study might not be
representative of the general population, although
they likely reﬂect a conservative overestimate of true
national referral rates.CONCLUSIONS
We report low rates of referral to cardiac rehabilita-
tion after PCI in the United States between 2009 and
2012, with >40% of patients not referred by the time
of hospital discharge. Our study highlights signiﬁcant
interhospital variability in referral rates and suggests
that unidentiﬁed, hospital-level factors may have a
stronger inﬂuence on referral rates than most patient-
speciﬁc factors, including insurance coverage for
rehabilitation programs (Central Illustration). The data
provide a useful baseline prior to public reporting by
CMS on hospital-speciﬁc rates of referral to cardiac
rehabilitation. Moreover, the ﬁndings support a call
to identify and assist underperforming institutions
through hospital-level interventions and ongoing ef-
forts to monitor for future improvements in national
cardiac rehabilitation referral rates.
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